clinical trial · NCT07681713
Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
Friedreich's AtaxiaVatiquinone
brief summary
The purpose of this study is to confirm the treatment effects of vatiquinone on the key measures of FA disease progression.
started
Aug 15, 2026
primary completion
Mar 15, 2029
completion
Mar 15, 2029
last updated
Aug 14, 2026
official title
Evaluation of Long-Term Efficacy of Vatiquinone for the Treatment of Friedreich's Ataxia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol